Jun 24, 2021 12:50 PM IST
Dhanuka Laboratories will sell 8.04 percent of the total share of the company on June 24 and June 25 via an offer for sale.
- Feb 10, 2021 01:33 PM IST
- Feb 10, 2021 01:33 PM IST
- Jul 01, 2020 10:22 AM IST
- Jul 01, 2020 10:13 AM IST
- Nov 18, 2019 08:44 PM IST
The appellate tribunal observed that the approved resolution value, which stood at Rs 1,146.04 crore, proposed by Dhanuka Laboratories was lower than the liquidation value of Rs 1,309 crore of the company.
- Aug 13, 2019 02:55 PM IST
- Aug 13, 2019 01:25 PM IST
- Feb 13, 2019 02:02 PM IST
- Jan 08, 2018 03:10 PM IST
The pharma company informed exchanges that it has received the establishment inspection report from the US Food and Drug Administration on successful inspection closure for Chennai plant.
- Dec 13, 2017 03:32 PM IST
In a filing to BSE, the company said it "has received ANDA (abbreviated new drug application) approval from USFDA (United States Food and Drug Administration) for Aripiprazole Orally-Disintegrating tablets USP, 10 mg and 15 mg."
- Sep 21, 2017 03:33 PM IST
The company has received EIR from the United States Food and Drug Administration (USFDA) based on the successful inspection of the active pharmaceutical ingredients (API) manufacturing facility at Alathur, Orchid Pharma said in a filing to BSE.
- Jul 26, 2017 08:41 AM IST
In an order dated July 24, the Securities and Exchange Board of India (Sebi) settled the "possible proceedings" against Orchid Pharma related to alleged non-compliances by the firm of Sebi's ICDR (Issue of Capital and Disclosure Requirements) Regulations.
- Apr 18, 2017 02:56 PM IST
Ashwani Gujral of ashwanigujral.com recommends buying Reliance Infra, OBC and Reliance Capital.
- Apr 18, 2017 01:02 PM IST
Orchid Pharma received the establishment inspection report from the US Food & Drug Administration.
- Apr 07, 2017 03:46 PM IST
Vijay Chopra of enochventures.com advises selling Orchid Pharma.
- Apr 07, 2017 03:36 PM IST
According to Prakash Gaba of prakashgaba.com, one may exit Orchid Pharma.
- Feb 20, 2017 03:26 PM IST
Avinash Gorakshakar, Market Expert advises exiting Orchid Pharma and one can prefer Lupin and Sun Pharmaceutical Industries.
- Feb 20, 2017 03:25 PM IST
According to Prakash Gaba of prakashgaba.com, one may exit Orchid Pharma closer to Rs 36.
- Feb 08, 2017 08:00 AM IST
Infosys | Idea Cellular | Axis Bank | Tata Steel | Bharti Airtel | Bharat Forge | Hero Motocorp | Godawari Power | Jubilant Life Sciences | NHPC | Quess Corp | Titan Company and Jindal Stainless are stocks, which are in the news today.
- Feb 07, 2017 04:28 PM IST
The company had posted a net loss of Rs 94.02 crore in the year-ago period, Orchid Pharma said in a BSE filing.
- Nov 11, 2016 04:13 PM IST
According to Prakash Gaba of prakashgaba.com, one may sell Orchid Pharma.
- Nov 10, 2016 08:00 AM IST
Sun Pharma | Tata Steel | Cipla | Emkay Global | FDC | Bosch | Dhampur Sugar | Parag Milk | Narayana Hrudayalaya | IG Petro | Snowman Logistics | Jamna Auto | Caplin Point | Power Grid | Ramco Systems | UCO Bank | TBZ | Apollo Tyres and Tata Global are stocks, which are in the news today.
- May 30, 2016 08:01 AM IST
Sun Pharma | Tata Motors | M&M | Hindalco Industries | Coal India | Tech Mahindra | Sun TV Network | Religare Enterprises | Suzlon Energy | Maruti Suzuki and Diamond Power are stocks, which are in the news today.
- Apr 21, 2016 08:00 AM IST
Manish Sharma of derivativetradingresearch is of the view that one may buy Voltas with a target of Rs 310.